{"id":16,"date":"2016-11-02T14:22:38","date_gmt":"2016-11-02T14:22:38","guid":{"rendered":"http:\/\/portal.welsh-blood.org.uk\/wtail\/?page_id=16"},"modified":"2016-11-10T14:21:35","modified_gmt":"2016-11-10T14:21:35","slug":"publications","status":"publish","type":"page","link":"https:\/\/portal.welsh-blood.org.uk\/wtail\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"<div id=\"pl-16\"  class=\"panel-layout\" ><div id=\"pg-16-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-16-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-16-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<div class=\"su-spoiler su-spoiler-style-default su-spoiler-icon-arrow-circle-1 su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>Publications 2016<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\"><\/p>\n<ul>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/5-New-Alleles-with-Synonymous-Mutations-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street, Elaine Davies, Timothy Climer and Chris Darke &#8211; Five new HLA-A, B, DRB1, DQB1 alleles with synonymous mutations -A*01:01:65, A*01:01:66, B*44:03:35, DRB1*15:01:30 and DQB1*02:01:24<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/5-new-alleles-with-Nonsynonymous-Mutations-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street, Elaine Davies, Chris Harvey and Chris Darke &#8211; Five new HLA-A, B, C, DQB1 alleles with nonsynonymous mutations \u2013A*11:241, B*49:43, C*03:321, C*08:132 and DQB1*02:72<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/A-Further-Example-of-HLA-DQB1-Genetics-and-Serology-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street, Emma Cook and Chris Darke &#8211; A further example of HLA-DQB1*03:119 \u2013genetics and serology<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/A-New-HLA-DRB115-Allele-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street, Chris Harvey, Jayne Johnson, Chris Darke &#8211; A new HLA-DRB1*15 allele \u2013DRB1*15:112<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Epitopology-or-HLA-B-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street and Chris Darke &#8211; \u2018Epitopology\u2019 of HLA-B*14:08 and other HLA-B*14 allele products<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Relationship-between-HLA-donor-specific-antibodies-DSAs-detected-by-complement-dependent-cytotoxicity-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">B Rana, C Darke, MT Rees, F Edwards, E Burrows &#8211; Relationship between HLA donor specific antibodies (DSAs) detected by complement dependent cytotoxicity (CDC), Luminex single antigen bead (SAB) and C1q assays, and antibody mediated rejection (AMR) and C4d deposition, in renal transplants<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Relationship-between-the-complement-dependent-cytotoxicity-CDC-Luminex-single-antigen-bead-SAB-and-Luminex-C1q-assays-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">B Rana, C Darke, MT Rees, F Edwards, E Burrows &#8211; Relationship between the complement dependent cytotoxicity (CDC), Luminex single antigen bead (SAB) and Luminex C1q assays<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Serological-Confirmation-that-HLA-A2368-reacts-as-a-Short-HLA-A23-2016.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street and Chris Darke &#8211; Serological confirmation that the HLA-A*23:68 product reacts as a \u2018short\u2019 HLA-A23<\/a><\/li>\n<\/ul>\n<p><\/div><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-16-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-16-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-16-1-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<div class=\"su-spoiler su-spoiler-style-default su-spoiler-icon-arrow-circle-1 su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>Publications 2015<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\"><\/p>\n<ul>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/A-serological-comparison-of-HLA-A-2603-and-A-2608-2015.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street and Chris Darke &#8211; A serological comparison of HLA-A*26:03 and A*26:08<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Should-HLA-A43-be-an-official-split-of-HLA-A10-2015.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street and Chris Darke &#8211; Should HLA-A43 be an official split of HLA-A10?<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Some-observations-on-HLA-A-2608-and-its-specificity-2015.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Jane Street and Chris Darke &#8211; Some observations on HLA-A*26:08 and its specificity<\/a><\/li>\n<\/ul>\n<p><\/div><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-16-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-16-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-16-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<div class=\"su-spoiler su-spoiler-style-default su-spoiler-icon-arrow-circle-1 su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>Publications 2014<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\"><\/p>\n<ul>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/HLA-DQA1-frequencies-and-DRB1DQA1DQB1-haplotype-prevalence-in-blood-donors-resident-in-Wales-2014.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">A. J. Lemin, J. Johnson &amp; C. Darke &#8211; HLA-DQA1 frequencies and DRB1\/DQA1\/DQB1 haplotype prevalence in blood donors resident in Wales<\/a><\/li>\n<\/ul>\n<p><\/div><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-16-3\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-16-3-0\"  class=\"panel-grid-cell\" ><div id=\"panel-16-3-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"3\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<div class=\"su-spoiler su-spoiler-style-default su-spoiler-icon-arrow-circle-1 su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>Publications 2013<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\"><\/p>\n<ul>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/NO-EFFECT-OF-\u2018LUMINEX-ONLY\u2019-PRE-TRANSPLANT-DSAs-ON4-YEAR-KIDNEY-GRAFT-SURVIVAL-2013.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">D. Singleton, A. De\u2019Ath, M.T. Rees, A. Asderakis, D. Asprou &amp; C. Darke &#8211; NO EFFECT OF \u2018LUMINEX ONLY\u2019 PRE-TRANSPLANT DSAs ON4 YEAR KIDNEY GRAFT SURVIVAL<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/THE-EFFECT-OF-PRONASE-ON-HLA-AND-CD20-2013.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">Ryan Stevens &amp; Chris Darke &#8211; THE EFFECT OF PRONASE ON HLA AND CD20 ANTIGENS<\/a><\/li>\n<\/ul>\n<p><\/div><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-16-4\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-16-4-0\"  class=\"panel-grid-cell\" ><div id=\"panel-16-4-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"4\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<div class=\"su-spoiler su-spoiler-style-default su-spoiler-icon-arrow-circle-1 su-spoiler-closed\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-spoiler-title\" tabindex=\"0\" role=\"button\"><span class=\"su-spoiler-icon\"><\/span>Publications 2012<\/div><div class=\"su-spoiler-content su-u-clearfix su-u-trim\"><\/p>\n<ul>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/35-OF-NORMAL-MALE-NON-TRANSFUSED-BLOOD-DONORS-HAVE-APPARENT-HLA-ANTIBODIES-REACTIVE-BY-LABSCREEN-SINGLE-ANTIGEN-BEADS.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">H.L. Wicks, M.T. Rees &amp; C. Darke &#8211; 35% OF NORMAL MALE NON-TRANSFUSED BLOOD DONORS HAVE APPARENT HLA ANTIBODIES REACTIVE BY LABSCREEN SINGLE ANTIGEN BEADS<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Flow-Cytometry-Based-HLA-B57B58-ScreeningPrior-to-Abacavir-Prescription.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">R. Stevens, E. Coates, E. Cook, J. Street &amp; C. Darke &#8211; Flow Cytometry-Based HLA-B57\/B58 Screening Prior to Abacavir Prescription<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/REACTIVITY-OF-THE-\u2018HLA-B27\u2019-MONOCLONAL-ANTIBODYFD705-AGAINST-\u2018RARE\u2019-HLA-B27-PRODUCTS-AND-ITS-LIKELY-EPITOPE.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">J.Street, E. Coates &amp; C. Darke &#8211; REACTIVITY OF THE \u2018HLA-B27\u2019 MONOCLONAL ANTIBODYFD705 AGAINST \u2018RARE\u2019 HLA-B*27 PRODUCTS AND ITS LIKELY EPITOPE<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/RELEVANCE-OF-PRE-TRANSPLANT-DONOR-SPECIFIC-ANTIBODIES-DETECTED-BY-LUMINEX-ONLY.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">D. Singleton, A. De\u2019Ath, M.T. Rees, A. Asderakis, D. Asprou &amp; C. Darke &#8211; RELEVANCE OF PRE-TRANSPLANT DONOR SPECIFIC ANTIBODIES DETECTED BY LUMINEX ONLY ON RENAL GRAFT REJECTION<\/a><br \/>\n<hr \/>\n<\/li>\n<li><a href=\"\/wtail\/wp-content\/uploads\/sites\/2\/2016\/11\/Sequence-Based-HLA-Typing-of-1000-Young-Donors-on-the-Welsh-Bone-Marrow-Donor-Registry.pdf\" class=\"mtli_attachment mtli_pdf\" target=\"_blank\">J. Pepperall, J. Johnson, J. Street &amp; C. Darke &#8211; Sequence-Based HLA Typing of 1,000 Young Donors on the Welsh Bone Marrow Donor Registry<\/a><\/li>\n<\/ul>\n<p><\/div><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-16-5\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-16-5-0\"  class=\"panel-grid-cell\" ><div id=\"panel-16-5-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"5\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p>Please click <a href=\"\/wtail\/request-a-publication\/\">HERE<\/a> to request older publications<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Publications 2016 Jane Street, Elaine Davies, Timothy Climer and Chris Darke &#8211; Five new HLA-A, B, DRB1, DQB1 alleles with synonymous mutations -A*01:01:65, A*01:01:66, B*44:03:35, DRB1*15:01:30 and DQB1*02:01:24 Jane Street, Elaine Davies, Chris Harvey and Chris Darke &#8211; Five new HLA-A, B, C, DQB1 alleles with nonsynonymous mutations \u2013A*11:241, B*49:43, C*03:321, C*08:132 and DQB1*02:72 Jane\u2026 <span class=\"read-more\"><a href=\"https:\/\/portal.welsh-blood.org.uk\/wtail\/publications\/\">Read More &raquo;<\/a><\/span><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-16","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/pages\/16","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/comments?post=16"}],"version-history":[{"count":26,"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/pages\/16\/revisions"}],"predecessor-version":[{"id":218,"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/pages\/16\/revisions\/218"}],"wp:attachment":[{"href":"https:\/\/portal.welsh-blood.org.uk\/wtail\/wp-json\/wp\/v2\/media?parent=16"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}